Nemaura Pharma
Advanced Technology Centre
Oakwood Drive
Loughborough
Leicestershire
LE11 3QF
United Kingdom
Tel: 44-0-1509-222-910
Website: http://www.nemaura.co.uk/
Email: enquiries@nemaura.co.uk
About Nemaura Pharma
A private specialist biotech company, Nemaura Pharma is strategically positioned to work with global pharmaceutical companies, as well as new biotechnology companies, to successfully bring both new and old drugs to patients in superior delivery formulations and systems. Ultimately, we aim to improve patient lifestyle and quality of life.YEAR FOUNDED:
2005
LEADERSHIP:
CEO: Faz Chowdhury
CLINICAL TRIAL:
Please click here for clinical trial information.
8 articles about Nemaura Pharma
-
Nemaura Pharma UK and Sparsha USA Announce Exclusive Strategic Collaboration
9/27/2019
Nemaura Pharma Limited, a UK based Biopharmaceutical company specializing in transdermal and injectable drug delivery systems announced a strategic collaboration with Sparsha USA.
-
Nemaura Announces License Agreement for 3 New Transdermal Patch Developments, and 48 Hour Diclofenac Patch Debut at CPhI Madrid
9/17/2018
Nemaura Pharma today announced it has entered into a license agreement with a Global Pharma Company to develop 3 new Transdermal Patch products.
-
Nemaura Pharma Wins UK Award for Innovation in Drug Delivery
4/27/2018
Nemaura Pharma has been recognised for its excellence in innovation by the leading UK life sciences body Medilink UK.
-
Improved NSAID Gels With 3x Faster Penetration Rates and 48 Hour Sustained Release Developed by Nemaura Pharma
11/1/2017
Sufferers of acute arthritic-related pain using ‘over the counter’ gels to alleviate muscle ache and joint inflammation may be interested in the results of laboratory trials recently carried out by Nemaura Pharma.
-
Loughborough, UK: Further industry Award For Nemaura Pharma
7/12/2017
-
Nemaura Pharma Memspatch Addresses Diabetics Fear Of Needle Puncture Pain
5/18/2017
-
Nemaura Pharma Appoints Dr. Werner Wessling As Director Of Strategic Alliances
4/7/2017
-
Nemaura Pharma Secures Funding To Advance Its Micro-Patch Solid Dose Microneedle System For A Hormone Biologic
2/7/2017